Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones11-21

DJ Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Incyte Corp. $(INCY)$ inched 0.69% higher to $71.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 5,917.11 and the Dow Jones Industrial Average rising 0.32% to 43,408.47.

Incyte Corp. closed $12.90 short of its 52-week high ($83.95), which the company reached on November 8th.

The stock underperformed when compared to some of its competitors Wednesday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 6.20% to $248.79.

Trading volume (2.1 M) eclipsed its 50-day average volume of 2.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

November 20, 2024 17:15 ET (22:15 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2485174378?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-21 06:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2485174378","market":"hk","top_or_hot":-1,"title":"Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Incyte Corp. <a href=\"https://laohu8.com/S/INCY\">$(INCY)$</a> inched 0.69% higher to $71.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&amp;P 500 Index  remaining mostly unchanged at 5,917.11 and the Dow Jones Industrial Average  rising 0.32% to 43,408.47. \n</p>\n<p>\n     Incyte Corp. closed $12.90 short of its 52-week high ($83.95), which the company reached on November 8th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Wednesday, as Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> rose 6.20% to $248.79. \n</p>\n<p>\n     Trading volume (2.1 M) eclipsed its 50-day average volume of 2.1 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 20, 2024 17:15 ET (22:15 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIncyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-21 06:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INCY","symbol_name":"因塞特医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2485174378","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2485174378","pubTimestamp":1732140900,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  inched 0.69% higher to $71.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 5,917.11 and the Dow Jones Industrial Average  rising 0.32% to 43,408.47.Incyte Corp. closed $12.90 short of its 52-week high , which the company reached on November 8th.The stock underperformed when compared to some of its competitors Wednesday, as Alnylam Pharmaceuticals Inc.  rose 6.20% to $248.79.Trading volume  eclipsed its 50-day average volume of 2.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"INCY":"因塞特医疗"},"translate_title":"尽管每日上涨，但与竞争对手相比，Incyte Corp.股票周三表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INCY":1},"content_text":"DJ Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Incyte Corp. $(INCY)$ inched 0.69% higher to $71.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 5,917.11 and the Dow Jones Industrial Average  rising 0.32% to 43,408.47. \n\n\n     Incyte Corp. closed $12.90 short of its 52-week high ($83.95), which the company reached on November 8th. \n\n\n     The stock underperformed when compared to some of its competitors Wednesday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 6.20% to $248.79. \n\n\n     Trading volume (2.1 M) eclipsed its 50-day average volume of 2.1 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 20, 2024 17:15 ET (22:15 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485174378"}